Marathon Asset Management (UK)’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Sell |
|
|||||
|
2025
Q1 | $20.1M | Sell |
|
|||||
|
2024
Q4 | $18.2M | Sell |
|
|||||
|
2024
Q3 | $21.6M | Buy |
|
|||||
|
2024
Q2 | $19.6M | Sell |
|
|||||
|
2024
Q1 | $24.1M | Sell |
|
|||||
|
2023
Q4 | $23.9M | Buy |
|
|||||
|
2023
Q3 | $20.8M | Sell |
|
|||||
|
2023
Q2 | $24.7M | Sell |
|
|||||
|
2023
Q1 | $32.2M | Sell |
|
|||||
|
2022
Q4 | $40.8M | Sell |
|
|||||
|
2022
Q3 | $43.1M | Sell |
|
|||||
|
2022
Q2 | $82.6M | Sell |
|
|||||
|
2022
Q1 | $80.9M | Sell |
|
|||||
|
2021
Q4 | $89.4M | Buy |
|